BR0207451A - Derivados de quinolina, isoquinolina e ftalazina como antagonistas do hormÈnio liberador de gonadotropina - Google Patents
Derivados de quinolina, isoquinolina e ftalazina como antagonistas do hormÈnio liberador de gonadotropinaInfo
- Publication number
- BR0207451A BR0207451A BR0207451-6A BR0207451A BR0207451A BR 0207451 A BR0207451 A BR 0207451A BR 0207451 A BR0207451 A BR 0207451A BR 0207451 A BR0207451 A BR 0207451A
- Authority
- BR
- Brazil
- Prior art keywords
- isoquinoline
- quinoline
- releasing hormone
- gonadotropin releasing
- hormone antagonists
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
Abstract
"DERIVADOS DE QUINOLINA, ISOQUINOLINA E FTALAZINA COMO ANTAGONISTAS DO HORMÈNIO LIBERADOR DE GONADOTROPINA". A presente invenção refere-se a novos derivados de quinolina, isoquinolina e ftalazina como antagonistas do hormónio liberador da gonadotropina.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2001108271 DE10108271A1 (de) | 2001-02-21 | 2001-02-21 | Chinolin-, Isochinolin- und Phthalazinderivate als Antagonisten des Gonadotropin freisetzenden Hormons |
US27491401P | 2001-03-13 | 2001-03-13 | |
PCT/EP2002/001882 WO2002066437A1 (de) | 2001-02-21 | 2002-02-21 | Chinolin-, isochinolin- und phthalazinderivate als antagonisten des gonadotropin freisetzenden hormons |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0207451A true BR0207451A (pt) | 2004-06-01 |
Family
ID=26008581
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0207451-6A BR0207451A (pt) | 2001-02-21 | 2002-02-21 | Derivados de quinolina, isoquinolina e ftalazina como antagonistas do hormÈnio liberador de gonadotropina |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1362034A1 (pt) |
JP (1) | JP2004528298A (pt) |
CN (1) | CN1496354A (pt) |
AU (1) | AU2002247737B2 (pt) |
BG (1) | BG108165A (pt) |
BR (1) | BR0207451A (pt) |
CA (1) | CA2438709A1 (pt) |
CZ (1) | CZ20032514A3 (pt) |
HU (1) | HUP0303219A2 (pt) |
IL (1) | IL157303A0 (pt) |
MX (1) | MXPA03007348A (pt) |
NO (1) | NO325675B1 (pt) |
NZ (1) | NZ527597A (pt) |
PL (1) | PL367285A1 (pt) |
RU (1) | RU2280031C2 (pt) |
SK (1) | SK11622003A3 (pt) |
WO (1) | WO2002066437A1 (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112015023328A2 (pt) * | 2013-03-13 | 2017-07-18 | Flatley Discovery Lab | compostos de piridazinona e métodos para o tratamento de fibrose cística |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0876349B1 (en) * | 1995-10-19 | 2002-09-11 | Takeda Chemical Industries, Ltd. | Quinoline derivatives as gnrh antagonists |
CA2254974A1 (en) * | 1996-05-20 | 1997-11-27 | Mark Goulet | Antagonists of gonadotropin releasing hormone |
-
2002
- 2002-02-21 RU RU2003128647/04A patent/RU2280031C2/ru not_active IP Right Cessation
- 2002-02-21 AU AU2002247737A patent/AU2002247737B2/en not_active Ceased
- 2002-02-21 BR BR0207451-6A patent/BR0207451A/pt not_active IP Right Cessation
- 2002-02-21 CZ CZ20032514A patent/CZ20032514A3/cs unknown
- 2002-02-21 PL PL02367285A patent/PL367285A1/xx not_active Application Discontinuation
- 2002-02-21 HU HU0303219A patent/HUP0303219A2/hu unknown
- 2002-02-21 SK SK1162-2003A patent/SK11622003A3/sk unknown
- 2002-02-21 EP EP02716803A patent/EP1362034A1/de not_active Withdrawn
- 2002-02-21 WO PCT/EP2002/001882 patent/WO2002066437A1/de active IP Right Grant
- 2002-02-21 MX MXPA03007348A patent/MXPA03007348A/es active IP Right Grant
- 2002-02-21 NZ NZ527597A patent/NZ527597A/en unknown
- 2002-02-21 CN CNA028063597A patent/CN1496354A/zh active Pending
- 2002-02-21 CA CA002438709A patent/CA2438709A1/en not_active Abandoned
- 2002-02-21 JP JP2002565954A patent/JP2004528298A/ja active Pending
- 2002-02-21 IL IL15730302A patent/IL157303A0/xx unknown
-
2003
- 2003-08-20 NO NO20033698A patent/NO325675B1/no not_active IP Right Cessation
- 2003-09-09 BG BG108165A patent/BG108165A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
NO20033698D0 (no) | 2003-08-20 |
SK11622003A3 (sk) | 2004-01-08 |
PL367285A1 (en) | 2005-02-21 |
RU2280031C2 (ru) | 2006-07-20 |
AU2002247737B2 (en) | 2006-05-18 |
CA2438709A1 (en) | 2002-08-29 |
CZ20032514A3 (cs) | 2004-05-12 |
IL157303A0 (en) | 2004-02-19 |
NZ527597A (en) | 2004-10-29 |
JP2004528298A (ja) | 2004-09-16 |
MXPA03007348A (es) | 2003-12-04 |
WO2002066437A1 (de) | 2002-08-29 |
CN1496354A (zh) | 2004-05-12 |
NO20033698L (no) | 2003-10-20 |
NO325675B1 (no) | 2008-07-07 |
EP1362034A1 (de) | 2003-11-19 |
HUP0303219A2 (hu) | 2003-12-29 |
BG108165A (en) | 2004-08-31 |
RU2003128647A (ru) | 2005-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS6886A (is) | Kínasólín sem MMP-13 hindrar | |
MXPA02004666A (es) | Gelatinas recombinantes. | |
DE69926806D1 (de) | N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren | |
MY122771A (en) | Heterocyclically substituted benzimidazoles, their preparation and use thereof | |
DE69925133D1 (de) | Pyrrolobenzodiazepine | |
ATE355278T1 (de) | Isochinolinon derivate als parp inhibitoren | |
DE69926919D1 (de) | N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren | |
ATE242238T1 (de) | Chinolin- und chinazolin-verbindungen von therapeutischem nutzen, insbesondere zur behandlung von gutartiger prostatahyperplasie | |
HN1999000057A (es) | Mesilato de n-(etinifenilamino)-6,7-bis (2-metoxietoxi)-4-quinazolinamina anhidro y monohidratado. | |
BR0207543A (pt) | Quinolinona tricìclica e quinolina tricìclica como compostos moduladores de receptor de androgênio | |
EA200200742A1 (ru) | 1,2-диарилбензимидазолы для лечения заболеваний, связанных с активацией микроглии | |
DE69614149T2 (de) | Chinolinderivate als antimalariamittel | |
UY26426A1 (es) | Nuevos compuestos | |
TR200103457T2 (tr) | 4-Fenil-Pirimidin Türevleri. | |
TR200000697T2 (tr) | İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları. | |
BR0012553A (pt) | Pastilhas contendo ambroxol | |
PT1107793E (pt) | Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados | |
BR0115139A (pt) | Compostos bis-heterocìclicos com atividade antitumor e quimiossensibilizante | |
PT1204659E (pt) | Benzofuranos serotoninergicos | |
BR0207451A (pt) | Derivados de quinolina, isoquinolina e ftalazina como antagonistas do hormÈnio liberador de gonadotropina | |
TR199901380A2 (xx) | Di-ya da triazo-spiro$4,5] dekan t�revleri | |
HK1046143A1 (en) | Substituted benzimidazole, the production thereof and the use thereof as means against parasitic protozoa | |
BR0308201A (pt) | Derivados de quinolina | |
NO20014059D0 (no) | Krystallmodifikasjon D av 8-cyano-1-cyklopropyl-7-(1S,6S-2,8- diazabicyklo-/4.3.0/-nonan-8-yl)-6-fluor-1,4-dihydro-4-okso-3-kinolinkarboksylsyre | |
DE60220699D1 (de) | Tibolonformulierungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A ANUIDADE(S). |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2103 DE 26/04/2011. |